The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atrovent Inhaler CFC-Free 20 micrograms per metered dose pressurised inhalation solution

20 microgram(s)/dose Pressurised inhalation, solution

Boehringer Ingelheim International GmbHPA0775/012/001

Main Information

Trade NameAtrovent Inhaler CFC-Free 20 micrograms per metered dose pressurised inhalation solution
Active SubstancesIpratropium bromide
Strength20 microgram(s)/dose
Dosage FormPressurised inhalation, solution
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberPA0775/012/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB01 ipratropium bromide

Status

Authorised/WithdrawnAuthorised
Licence Issued14/05/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back